Apogee Therapeutics (APGE) Net Income (2022 - 2026)
Apogee Therapeutics' (APGE) quarterly Net Income came in at -$74.1 million in Q1 2026, down 33.92% year-on-year from -$112.2 million in Q1 2025, and down 379.99% on a QoQ basis from -$15.4 million in Q4 2025.
Apogee Therapeutics (APGE) Net Income (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of Net Income data on file, last reported at -$74.1 million in Q1 2026.
- On a quarterly basis, Net Income fell 33.92% year-over-year to -$74.1 million in Q1 2026; TTM through Mar 2026 was -$220.7 million, a 7.73% decrease from a year earlier, with the FY2025 full-year figure at -$201.9 million, down 11.18% from the prior year.
- Net Income for Q1 2026 stood at -$74.1 million, down from -$15.4 million in the prior quarter.
- Over the last five years, Net Income for APGE reached as high as -$1.8 million in Q2 2022 and fell as low as -$74.1 million in Q1 2026.
- Historically, Net Income has averaged -$37.9 million across 5 years, with a median of -$33.0 million in 2024.
- Across the five-year window, Net Income slumped 939.92% in 2023 and surged 76.84% in 2025, its largest moves.
- Year by year, Net Income stood at -$20.8 million in 2022, then sank by 197.92% to -$61.9 million in 2023, then dropped by 7.66% to -$66.7 million in 2024, then jumped by 76.84% to -$15.4 million in 2025, then plunged by 379.99% to -$74.1 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$74.1 million in Q1 2026, -$15.4 million in Q4 2025, and -$65.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Apogee Therapeutics | 9.35 Bn | 8.29 Bn | - | -74.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.11 Mn |
| Dec 31, 2025 | -15.44 Mn |
| Sep 30, 2025 | -65.02 Mn |
| Jun 30, 2025 | -66.10 Mn |
| Mar 31, 2025 | -55.34 Mn |
| Dec 31, 2024 | -66.66 Mn |
| Sep 30, 2024 | -49.02 Mn |
| Jun 30, 2024 | -33.82 Mn |
| Mar 31, 2024 | -32.09 Mn |
| Dec 31, 2023 | -61.91 Mn |
| Sep 30, 2023 | -22.16 Mn |
| Jun 30, 2023 | -18.89 Mn |
| Mar 31, 2023 | -12.53 Mn |
| Dec 31, 2022 | -20.78 Mn |
| Sep 30, 2022 | -10.51 Mn |
| Jun 30, 2022 | -1.82 Mn |